Fix buffer 1
Fix Buffer I is a laboratory solution used to preserve and stabilize biological samples. It is designed to maintain the structural integrity and chemical properties of proteins, nucleic acids, and other biomolecules.
Lab products found in correlation
63 protocols using fix buffer 1
Phospho-specific Flow Cytometry Protocol
Profiling PD-L1 and pSTAT1 in SV40-Fibroblasts
Quantifying p-STAT5 in Immune Cells
Targeted Inhibition of IFN Signaling in B Cells
Example 4
The type I IFN antagonist IFNα2-R120E was fused to the anti-human CD20 nanobody 2HCD25 through a linker sequence made with 20 repeats of GGS motif. The fusion protein was produced in E. coli and purified by Immobilized Metal Affinity chromatography (IMAC).
Human peripheral blood mononuclear cells (PBMCs) are expected to contain ≈4% of B-cells which can be characterized by the cell surface expression of CD19. The large majority of circulating B-cells are also positive for the expression of CD20.
PBMCs were isolated over ficoll gradient (histopaque-1077, Sigma-Aldrich) from blood samples of healthy donors. Cells were left untreated or were incubated for 15 minutes with 50 pM of human IFNα2 in the absence or presence of 10 μg/ml of the 2HCD25 nanobody-IFNα2-R120E fusion protein.
Cells were then fixed (BD Fix Buffer I), permeabilized (BD Perm Buffer III) and labelled with PE-labelled anti pSTAT1 (BD #612564) and APC-labelled anti human CD19 (BD #555415). FACS data were acquired using a BD FACS Canto and analyzed using Diva (BD Biosciences) software for the fluorescence associated with pSTAT1 in CD19 positive and negative cell populations.
Characterization of Cultured TIL Phenotypes
Mutagenesis and FACS Sorting of HAP1 Cells
Phosphorylation Analysis of Tregs
Flow Cytometry Analysis of Immune Cells
Phospho-flow Cytometry of Treg Cells
Multiparametric Flow Cytometry Analysis
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!